# SpyGlass in Preoperative Diagnostics of Presumed Main Duct IPMNs: Efficacy and Novel Insights on Complications

> **NCT03062124** · — · COMPLETED · sponsor: **Helsinki University Central Hospital** · enrollment: 101 (actual)

## Conditions studied

- Intraductal Papillary Mucinous Neoplasm

## Interventions

- **PROCEDURE:** SpyGlass pancreatoscopy

## Key facts

- **NCT ID:** NCT03062124
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-18
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2021-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062124, "SpyGlass in Preoperative Diagnostics of Presumed Main Duct IPMNs: Efficacy and Novel Insights on Complications". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03062124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*